Review article · 2026 · Open access

AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases

Soukaina Amniouel, Zeenat A. Shyr, Ewy A. Mathé, Wei Zheng

Drug Discovery Today, 31(6), 104836 · Published 16 October 2026 · DOI 10.1016/j.drudis.2026.104836

Open PDFView at the publisherCite this paper

In brief

“AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases” is a 2026 review article by Soukaina Amniouel and 3 co-authors, published in Drug Discovery Today. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY licence: the full text is free to read at Drug Discovery Today.

Citations
0
References
83
Authors
4

Abstract

Rare diseases represent a major unmet medical need, yet the development of therapeutics for these diseases is limited by small patient cohorts, fragmented data, and uncertain disease mechanisms. Recent advances that combine patient-derived induced pluripotent stem cell (iPSC) models with multi-omics profiling and artificial intelligence offer a robust approach for phenotype definition and drug target identification that requires only minimal patient material. By integrating transcriptomic, proteomic, and metabolomic data, machine learning can produce disease-relevant molecular signatures, identify convergent pathway drivers, and prioritize druggable targets despite limited sample sizes. This short review highlights emerging in vitro models and AI-enabled workflows, discusses their strengths and limitations, and outlines practical strategies to accelerate drug discovery for rare diseases.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Amniouel, S., Shyr, Z. A., Mathé, E. A., & Zheng, W. (2026). AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases. Drug Discovery Today, 31(6), 104836. https://doi.org/10.1016/j.drudis.2026.104836

MLA 9

Amniouel, Soukaina, et al. “AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases.” Drug Discovery Today, vol. 31, no. 6, 2026, p. 104836. https://doi.org/10.1016/j.drudis.2026.104836.

Chicago

Amniouel, Soukaina, Zeenat A. Shyr, Ewy A. Mathé, and Wei Zheng. 2026. “AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases.” Drug Discovery Today 31 (6): 104836. https://doi.org/10.1016/j.drudis.2026.104836.

Harvard

Amniouel, S. et al. (2026) ‘AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases’, Drug Discovery Today, 31(6), p. 104836. doi:10.1016/j.drudis.2026.104836.

IEEE

S. Amniouel, Z. A. Shyr, E. A. Mathé, and W. Zheng, “AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases,” Drug Discovery Today, vol. 31, no. 6, p. 104836, 2026, doi: 10.1016/j.drudis.2026.104836.

BibTeX

@article{amniouel2026integrated,
  title     = {{AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases}},
  author    = {Amniouel, Soukaina and Shyr, Zeenat A. and Mathé, Ewy A. and Zheng, Wei},
  journal   = {Drug Discovery Today},
  year      = {2026},
  volume    = {31},
  number    = {6},
  pages     = {104836},
  doi       = {10.1016/j.drudis.2026.104836},
  url       = {https://doi.org/10.1016/j.drudis.2026.104836}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • rare diseases
  • induced pluripotent stem cells
  • iPSC-derived disease models
  • multi-omics integration
  • artificial intelligence
  • drug target identification
  • transcriptomics
  • proteomics

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Amniouel, S., Shyr, Z. A., Mathé, E. A., & Zheng, W. (2026). AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases. Drug Discovery Today, 31(6), 104836. https://doi.org/10.1016/j.drudis.2026.104836

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Drug Discovery Today: sign in and open the PDF from this page.

Who wrote this paper?

Soukaina Amniouel, Zeenat A. Shyr, Ewy A. Mathé, Wei Zheng.

What is the DOI of this paper?

10.1016/j.drudis.2026.104836, permanently at https://doi.org/10.1016/j.drudis.2026.104836. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.